Noncollagenous Bone Matrix Proteins

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 335-349

  Gehron Robey, Pamela ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866850550     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00036-7     Document Type: Chapter

References (92)

1. J.C. Adams and J. Lawler (2004) The thrombospondins. Int. J. Biochem. Cell. Biol. 36 961-968.
2. L. Addadi and S. Weiner (1985) Interactions between acidic proteins and crystals: Stereochemical requirements in biomineralization. Proc. Natl. Acad. Sci. USA. 82 4110-4114.
3. L. Ameye, D. Aria, K. Jepsen, A. Oldberg, T. Xu and M.F. Young (2002) Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 16 673-680.
4. J.A. Bassuk, T. Birkebak, J.D. Rothmier, J.M. Clark, A. Bradshaw, P.J. Muchowski, C.C. Howe, J.I. Clark and E.H. Sage (1999) Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp. Eye Res. 68 321-331.
5. A. Bellahcene, V. Albert, L. Pollina, F. Basolo, L.W. Fisher and V. Castronovo (1998) Ectopic expression of bone sialoprotein in human thyroid cancer. Thyroid. 8 637-641.
6. A. Bellahcene and V. Castronovo (1997) Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bull. Cancer. 84 17-24.
7. A. Bellahcene, V. Castronovo, K.U. Ogbureke, L.W. Fisher and N.S. Fedarko (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat. Rev. Cancer. 8 212-226.
8. A. Bellahcene, N. Maloujahmoum, L.W. Fisher, H. Pastorino, E. Tagliabue, S. Menard and V. Castronovo (1997) Expression of bone sialoprotein in human lung cancer. Calcif. Tissue Int. 61 183-188.
9. S. Bhattacharya, C.G. Bunick and W.J. Chazin (2004) Target selectivity in EF-hand calcium binding proteins. Biochim. Biophys. Acta. 1742 69-79.
10. P. Bianco, L.W. Fisher, M.F. Young, J.D. Termine and P.G. Robey (1990) Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38 1549-1563.
11. P. Bianco, L.W. Fisher, M.F. Young, J.D. Termine and P.G. Robey (1991) Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int. 49 421-426.
12. A. Bini, K.G. Mann, B.J. Kudryk and F.J. Schoen (1999) Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 19 1852-1861.
13. C. Binkert, M. Demetriou, B. Sukhu, M. Szweras, H.C. Tenenbaum and J.W. Dennis (1999) Regulation of osteogenesis by fetuin. J. Biol. Chem. 274 28514-28520.
14. L.F. Bonewald (2006) Mechanosensation and transduction in osteocytes. Bonekey Osteovis. 3 7-15.
15. A.D. Bradshaw and E.H. Sage (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 107 1049-1054.
16. A.E. Canfield, M.J. Doherty, A.C. Wood, C. Farrington, B. Ashton, N. Begum, B. Harvey, A. Poole, M.E. Grant and R.P. Boot-Handford (2000) Role of pericytes in vascular calcification: A review. Z. Kardiol. 89(Suppl 2), 20-27.
17. J.A. Carron, W.B. Bowler, S.C. Wagstaff and J.A. Gallagher (1999) Expression of members of the thrombospondin family by human skeletal tissues and cultured cells. Biochem. Biophys. Res. Commun. 263 389-391.
18. G. Chakraborty, S. Jain, R. Behera, M. Ahmed, P. Sharma, V. Kumar and G.C. Kundu (2006) The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr. Mol. Med. 6 819-830.
19. S. Chakravarti, J. Paul, L. Roberts, I. Chervoneva, A. Oldberg and D.E. Birk (2003) Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest. Ophthalmol. Vis. Sci. 44 2422-2432.
20. S.S. Chaudhry, S.A. Cain, A. Morgan, S.L. Dallas, C.A. Shuttleworth and C.M. Kielty (2007) Fibrillin-1 regulates the bioavailability of TGFbeta1. J. Cell Biol. 176 355-367.
21. A. Corsi, T. Xu, X.D. Chen, A. Boyde, J. Liang, M. Mankani, B. Sommer, R.V. Iozzo, I. Eichstetter, P.G. Robey, P. Bianco and M.F. Young (2002) Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17 1180-1189.
22. K.G. Danielson, H. Baribault, D.F. Holmes, H. Graham, K.E. Kadler and R.V. Iozzo (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136 729-743.
23. A.M. Delany, M. Amling, M. Priemel, C. Howe, R. Baron and E. Canalis (2000) Osteopenia and decreased bone formation in osteonectin-deficient mice. J. Clin. Invest. 105 915-923.
24. P.D. Delmas, R.P. Tracy, B.L. Riggs and K.G. Mann (1984) Identification of the noncollagenous proteins of bovine bone by two-dimensional gel electrophoresis. Calcif. Tissue Int. 36 308-316.
25. M. Demetriou, C. Binkert, B. Sukhu, H.C. Tenenbaum and J.W. Dennis (1996) Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J. Biol. Chem. 271 12755-12761.
26. P. Ducy, C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley and G. Karsenty (1996) Increased bone formation in osteocalcin-deficient mice. Nature. 382 448-452.
27. P. Ducy, R. Zhang, V. Geoffroy, A.L. Ridall and G. Karsenty (1997) Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell. 89 747-754.
28. S. El-Maadawy, M.T. Kaartinen, T. Schinke, M. Murshed, G. Karsenty and M.D. McKee (2003) Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect. Tissue Res. 44(Suppl 1), 272-278.
29. N.S. Fedarko, A. Jain, A. Karadag and L.W. Fisher (2004) Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J. 18 734-736.
30. N.S. Fedarko, U.K. Vetter, S. Weinstein and P.G. Robey (1992) Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J. Cell Physiol. 151 215-227.
31. J.Q. Feng, L.M. Ward, S. Liu, Y. Lu, Y. Xie, B. Yuan, X. Yu, F. Rauch, S.I. Davis, S. Zhang, H. Rios, M.K. Drezner, L.D. Quarles, L.F. Bonewald and K.E. White (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38 1310-1315.
32. L.W. Fisher and N.S. Fedarko (2003) Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect. Tissue Res. 44(Suppl 1), 33-40.
33. L.W. Fisher, O.W. McBride, J.D. Termine and M.F. Young (1990) Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J. Biol. Chem. 265 2347-2351.
34. L.W. Fisher and J.D. Termine (1985) Noncollagenous proteins influencing the local mechanisms of calcification. Clin. Orthop. Rel. Res. 200, 362–385. 4 362-385.
35. L.W. Fisher, J.D. Termine and M.F. Young (1989) Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264 4571-4576.
36. J. Garnett and P. Dieppe (1990) The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem. J. 266 863-868.
37. L. Gleghorn, R. Ramesar, P. Beighton and G. Wallis (2005) A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am. J. Hum. Genet. 77 484-490.
38. L.C. Gowen, D.N. Petersen, A.L. Mansolf, H. Qi, J.L. Stock, G.T. Tkalcevic, H.A. Simmons, D.T. Crawford, K.L. Chidsey-Frink, H.Z. Ke, J.D. McNeish and T.A. Brown (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J. Biol. Chem. 278 1998-2007.
39. W.J. Grzesik and P.G. Robey (1994) Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J. Bone Miner. Res. 9 487-496.
40. K.D. Hankenson, B.J. Ausk, S.D. Bain, P. Bornstein, T.S. Gross and S. Srinivasan (2006) Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading. Bone 38 310-316.
41. E. Hedbom and D. Heinegard (1993) Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J. Biol. Chem. 268 27307-27312.
42. S.P. Henry, M. Takanosu, T.C. Boyd, P.M. Mayne, H. Eberspaecher, W. Zhou, B. de Crombrugghe, M. Hook and R. Mayne (2001) Expression pattern and gene characterization of asporin. A newly discovered member of the leucine-rich repeat protein family. J. Biol. Chem. 276 12212-12221.
43. G.M. Herring and B.A. Ashton (1974) The isolation of soluble proteins, glycoproteins, and proteoglycans from bone. Prep. Biochem. 4 179-200.
44. K. Iba, M.E. Durkin, L. Johnsen, E. Hunziker, K. Damgaard-Pedersen, H. Zhang, E. Engvall, R. Albrechtsen and U.M. Wewer (2001) Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity. Mol. Cell. Biol. 21 7817-7825.
45. W. Jahnen-Dechent, T. Schinke, A. Trindl, W. Muller-Esterl, F. Sablitzky, S. Kaiser and M. Blessing (1997) Cloning and targeted deletion of the mouse fetuin gene. J. Biol. Chem. 272 31496-31503.
46. A. Javed, G.L. Barnes, B.O. Jasanya, J.L. Stein, L. Gerstenfeld, J.B. Lian and G.S. Stein (2001) runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol. Cell Biol. 21 2891-2905.
47. R. Kasai, P. Bianco, P.G. Robey and A.J. Kahn (1994) Production and characterization of an antibody against the human bone GLA protein (BGP/osteocalcin) propeptide and its use in immunocytochemistry of bone cells. Bone Miner. 25 167-182.
48. B. Kobe and J. Deisenhofer (1995) Proteins with leucine-rich repeats. Curr. Opin. Struct. Biol. 5 409-416.
49. T. Komori, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki and T. Kishimoto (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 755-764.
50. F. Lamoureux, M. Baud’huin, L. Duplomb, D. Heymann and F. Redini (2007) Proteoglycans: Key partners in bone cell biology. BioEssays. 29 758-771.
51. N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy and G. Karsenty (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130 456-469.
52. P. Lorenzo, A. Aspberg, P. Onnerfjord, M.T. Bayliss, P.J. Neame and D. Heinegard (2001) Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J. Biol. Chem. 276 12201-12211.
53. B.H. Luo, C.V. Carman and T.A. Springer (2007) Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25 619-647.
54. G. Luo, P. Ducy, M.D. McKee, G.J. Pinero, E. Loyer, R.R. Behringer and G. Karsenty (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386 78-81.
55. C. Maillard, M. Berruyer, C.M. Serre, M. Dechavanne and P.D. Delmas (1992) Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 130 1599-1604.
56. F.C. Mansergh, T. Wells, C. Elford, S.L. Evans, M.J. Perry, M.J. Evans and B.A. Evans (2007) Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiol. Genomics. 32 64-73.
57. N. Matsushima, T. Ohyanagi, T. Tanaka and R.H. Kretsinger (2000) Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans—biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin. Proteins. 38 210-225.
58. P.A. McEwan, P.G. Scott, P.N. Bishop and J. Bella (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J. Struct. Biol. 155 294-305.
59. K.P. Mintz, W.J. Grzesik, R.J. Midura, P.G. Robey, J.D. Termine and L.W. Fisher (1993) Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain. J. Bone Miner. Res. 8 985-995.
60. O. Nakamura, J.A. Kazi, T. Ohnishi, N. Arakaki, Q. Shao, T. Kajihara and Y. Daikuhara (1999) Effects of rat fetuin on stimulation of bone resorption in the presence of parathyroid hormone. Biosci. Biotechnol. Biochem. 63 1383-1391.
61. K.U. Ogbureke and L.W. Fisher (2004) Expression of SIBLINGs and their partner MMPs in salivary glands. J. Dent. Res. 83 664-670.
62. K.U. Ogbureke and L.W. Fisher (2005) Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int. 68 155-166.
63. T. Ohnishi, O. Nakamura, M. Ozawa, N. Arakaki, T. Muramatsu and Y. Daikuhara (1993) Molecular cloning and sequence analysis of cDNA for a 59kD bone sialoprotein of the rat: demonstration that it is a counterpart of human alpha 2-HS glycoprotein and bovine fetuin. J. Bone Miner. Res. 8 367-377.
64. R. Pankov and K.M. Yamada (2002) Fibronectin at a glance. J. Cell Sci. 115 3861-3863.
65. P.A. Price, J.W. Poser and N. Raman (1976) Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc. Natl. Acad. Sci. USA. 73 3374-3375.
66. P.A. Price, M.R. Urist and Y. Otawara (1983) Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem. Biophys. Res. Commun. 117 765-771.
67. D. Primorac, C.V. Johnson, J.B. Lawrence, M.B. McKinstry, M.L. Stover, M.S. Schanfield, S. Andjelinovic, T. Tadic and D.W. Rowe (1999) Premature termination codon in the aggrecan gene of nanomelia and its influence on mRNA transport and stability. Croat. Med. J. 40 528-532.
68. L. Purcell, J. Gruia-Gray, S. Scanga and M. Ringuette (1993) Developmental anomalies of Xenopus embryos following microinjection of SPARC antibodies. J. Exp. Zool. 265 153-164.
69. F. Ramirez and H.C. Dietz (2007) Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. J. Cell. Physiol. 213 326-330.
70. P.G. Robey, M.F. Young, L.W. Fisher and T.D. McClain (1989) Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J. Cell Biol. 108 719-727.
71. P.S. Rowe (2004) The wrickkened pathways of FGF23, MEPE and PHEX. Crit. Rev. Oral Biol. Med. 15 264-281.
72. P.S. Rowe, P.A. de Zoysa, R. Dong, H.R. Wang, K.E. White, M.J. Econs and C.L. Oudet (2000) MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67 54-68.
73. M. Scatena, L. Liaw and C.M. Giachelli (2007) Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27 2302-2309.
74. E. Schonherr and H.J. Hausser (2000) Extracellular matrix and cytokines: A functional unit. Dev. Immunol. 7 89-101.
75. I. Schvartz, D. Seger and S. Shaltiel (1999) Vitronectin. Int. J. Biochem. Cell Biol. 31 539-544.
76. D. Seiffert (1996) Detection of vitronectin in mineralized bone matrix. J. Histochem. Cytochem. 44 275-280.
77. Y. Sommarin, M. Wendel, Z. Shen, U. Hellman and D. Heinegard (1998) Osteoadherin, a cell-binding keratan sulfate proteoglycan in bone, belongs to the family of leucine-rich repeat proteins of the extracellular matrix. J. Biol. Chem. 273 16723-16729.
78. J.T. Stubbs Jr., K.P. Mintz, E.D. Eanes, D.A. Torchia and L.W. Fisher (1997) Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J. Bone Miner. Res. 12 1210-1222.
79. J.D. Termine, A.B. Belcourt, P.J. Christner, K.M. Conn and M.U. Nylen (1980) Properties of dissociatively extracted fetal tooth matrix proteins. I Principal molecular species in developing bovine enamel. J. Biol. Chem. 255 9760-9768.
80. J.D. Termine, A.B. Belcourt, K.M. Conn and H.K. Kleinman (1981) Mineral and collagen-binding proteins of fetal calf bone. J. Biol. Chem. 256 10403-10408.
81. M.A. Thiede, S.L. Smock, D.N. Petersen, W.A. Grasser, D.D. Thompson and S.K. Nishimoto (1994) Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135 929-937.
82. A. Trion and A. van der Laarse (2004) Vascular smooth muscle cells and calcification in atherosclerosis. Am. Heart J. 147 808-814.
83. M. Ujita, T. Shinomura and K. Kimata (1995) Molecular cloning of the mouse osteoglycin-encoding gene. Gene. 158 237-240.
84. G. van der Pluijm, H.J. Vloedgraven, B. Ivanov, F.A. Robey, W.J. Grzesik, P.G. Robey, S.E. Papapoulos and C.W. Lowik (1996) Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res. 56 1948-1955.
85. D. Waltregny, A. Bellahcene, I. Van Riet, L.W. Fisher, M. Young, P. Fernandez, W. Dewe, J. de Leval and V. Castronovo (1998) Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J. Natl. Cancer Inst. 90 1000-1008.
86. H. Watanabe, K. Kimata, S. Line, D. Strong, L.Y. Gao, C.A. Kozak and Y. Yamada (1994) Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat. Genet. 7 154-157.
87. U.M. Wewer, K. Ibaraki, P. Schjorring, M.E. Durkin, M.F. Young and R. Albrechtsen (1994) A potential role for tetranectin in mineralization during osteogenesis. J. Cell Biol. 127 1767-1775.
88. T.N. Wight (2002) Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14 617-623.
89. D.R. Williams Jr., A.R. Presar, A.T. Richmond, C.H. Mjaatvedt, S. Hoffman and A.A. Capehart (2005) Limb chondrogenesis is compromised in the versican deficient hdf mouse. Biochem. Biophys. Res. Commun. 334 960-966.
90. M. Wong, T. Lawton, P.F. Goetinck, J.L. Kuhn, S.A. Goldstein and J. Bonadio (1992) Aggrecan core protein is expressed in membranous bone of the chick embryo. Molecular and biomechanical studies of normal and nanomelia embryos. J. Biol. Chem. 267 5592-5598.
91. T. Xu, P. Bianco, L.W. Fisher, G. Longenecker, E. Smith, S. Goldstein, J. Bonadio, A. Boskey, A.M. Heegaard, B. Sommer, K. Satomura, P. Dominguez, C. Zhao, A.B. Kulkarni, P.G. Robey and M.F. Young (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20 78-82.
92. W. Zu, P.G. Robey and A.L. Boskey (2007) The biochemistry of bone. R. Marcus, D. Feldman, D.A. Nelson, C.J. Rosen (Eds) Osteoporosis Burlington, MA: Elsevier Science and Technology 191-240.